|
Kemp et al. (1997)
|
cohort
|
1,265 children born in 1977; followed through age 16 years (New Zealand)
|
DTP,* polio, measles by proxy
|
asthma, other allergic diseases by diary or questionnaire by proxy, and by medical records
|
Risk ratios for asthma episodes, asthma consults, and allergy consults for immunized children ages 0– 10 years were infinite (95% CI 1.03–infmity) because no events occurred in non-immunized group;
Risk ratios (95% CI), age 0.16 yrs; Asthma episodes: 2.9 (0.8-23.6) Asthma consults: 2.7 (0.7-22.3) Allergy consults: 5.6 (1.0-222.6)
Risk ratios for asthma episodes age 0–10 and measles vaccination: 1.0 (0.9-1.1)
|
weaknesses in study design include small number of unvaccinated children, marginal significance of results, potential for health care utilization bias; difficulty in adjusting for confounders (due to small number of unvaccinated)
|
weak evidence relevant to causality; favors no effect of any vaccine.
|
|
BCG = Bacille Calmette-Guerin vaccine
DTaP = diphtheria-tetanus-acellular pertussis
DTwP = diphtheria-tetanus-whole-cell pertussis
Hep B = hepatitis B vaccine
Hib = Haemophilus influenzae b vaccine
MMR = measles-mumps-rubella vaccine
HMO: health maintenance organization
NS = not significant
OR = odds ratio
RR = relative risk
CI = confidence interval
*These studies do not specify acellular or whole-cell pertussis vaccine. It is assumed that whole-cell pertussis vaccine is being administered to children in these studies.
|